My watch list
my.bionity.com  
Login  

Alzheimer's Disease

News Alzheimer's Disease

  • In the fight against Alzheimer's, Down syndrome may hold vital clues

    At first glance, Down syndrome (DS) and Alzheimer's disease (AD), two severe brain abnormalities, may seem to have little in common. Down syndrome is a hereditary disease, the source of which has long been recognized--a triplication of chromosome 21. By contrast, the overwhelming majority of Alzheim more

  • New method enables accurate diagnosis of Alzheimer's disease

    Diagnosing Alzheimer's disease can be difficult, as several other conditions can cause similar symptoms. Now a new brain imaging method can show the spread of specific tau protein depositions, which are unique to cases with Alzheimer's. "The method works very well. I believe it will be applied clini more

  • Why some people with brain markers of Alzheimer’s have no dementia

    A new study from The University of Texas Medical Branch at Galveston has uncovered why some people that have brain markers of Alzheimer’s never develop the classic dementia that others do. Alzheimer’s disease, the most common form of dementia, affects more than 5 million Americans. People suffering more

All news on alzheimer's disease

Videos Alzheimer's Disease

Chaperones - folding helpers in the cell

Nothing works without the correct form: For most proteins, there are millions of ways in which these molecules, composed of long chains of amino acids, can be folded - but only one way is the right one. Researchers in the department "Cellular Biochemistry" at the Max Planck Institute for Biochem ... more

White papers Alzheimer's Disease

Events Alzheimer's Disease

Webinar
On-Demand

Characterization of AD Animal Models: Building In Vivo Tools to Assess Next-Generation AD Therapeutics

Preclinical development of drug candidates for Alzheimer’s disease (AD) takes multiple different paths; animal models are indispensable tools to support diverse preclinical drug development programs. Charles River performs in-house evaluations employing several mouse models of AD using a range of up

Publications Alzheimer's Disease

All publications on alzheimer's disease

Market studies Alzheimer's Disease

  • Exelon (Alzheimer’s disease) – Analysis and Forecasts to 2022

    Introduction GlobalData’s pharmaceuticals report, “Exelon (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides Exelon global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales perf more

  • Alzheimer's Disease Global Clinical Trials Review, H2, 2012

    Introduction GlobalData's clinical trial report, “Alzheimer’s Disease Global Clinical Trials Review, H2, 2012" provides data on the Alzheimer’s Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alzheimer’s Disease. It includes a more

  • LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022

    Introduction GlobalData’s pharmaceuticals report, “LY2062430 (Alzheimer’s disease) – Analysis and Forecasts to 2022” provides LY2062430 global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sale more

All market studies on alzheimer's disease
Related topics
Definition

Alzheimer's disease

Alzheimer's disease Alzheimer's disease (AD), also called Alzheimer disease, and simply known as Alzheimer's, is a neurodegenerative disease that, in its most common form, is found in people over the age of 65. Approximately 24 million people ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE